Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06721065

A Study of Language Interpretation Solutions for People With Breast Cancer

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-05-12

700

Participants Needed

8

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with Limited English Proficiency/LEP (Stages II and III disease) and English- speaking providers (who do not speak Spanish/Mandarin). In Phase 2, there will be a sequential mixed-methods explanatory, multi-stakeholder process evaluation to gather implementation potential data.

CONDITIONS

Official Title

A Study of Language Interpretation Solutions for People With Breast Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Preferred healthcare language is Spanish or Mandarin
  • Limited English proficiency; cannot speak English "very well"
  • Diagnosis of breast cancer or gastrointestinal cancer
  • Visiting MSK oncology teams for first or second appointment
  • Agrees to be audio-recorded (patients and providers)
  • Provider is breast or gastrointestinal cancer specialist who does not speak Spanish and/or Mandarin
  • Clinic staff who worked at study sites during Phase 1 and agree to be audio-recorded
Not Eligible

You will not qualify if you...

  • Significant psychiatric disturbance preventing assessments or consent
  • Cognitive impairment (delirium or dementia) preventing meaningful consent or data collection
  • No exclusion criteria for providers or clinic staff

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Memorial Sloan Kettering Basking Ridge (Consent Only)

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

2

Memorial Sloan Kettering Monmouth (Consent Only)

Middletown, New Jersey, United States, 07748

Actively Recruiting

3

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, United States, 07645

Actively Recruiting

4

Memorial Sloan Kettering Suffolk- Commack (Consent Only)

Commack, New York, United States, 11725

Actively Recruiting

5

Memorial Sloan Kettering Westchester (Consent Only)

Harrison, New York, United States, 10604

Actively Recruiting

6

Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities)

New York, New York, United States, 10035

Actively Recruiting

7

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States, 10065

Actively Recruiting

8

Memorial Sloan Kettering Nassau (All Protocol Activities)

Rockville Centre, New York, United States, 11553

Actively Recruiting

Loading map...

Research Team

F

Francesca Gany, MD, MS

CONTACT

L

Lisa Diamond, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here